Top Markets
Coin of the day
Great Novel Therapeutics Biotech & Medicals Great Novel Therapeutics Biotech & Medicals

Great Novel Therapeutics Biotech & Medicals

7427
Classement en actions #20753
Great Novel Therapeutics Biotech & Medicals specializes in crafting... Great Novel Therapeutics Biotech & Medicals specializes in crafting pharmaceutical solutions to combat advanced and treatment-resistant cancers. Their primary focus lies in the realm of cancer immunotherapy, encompassing the creation of compounds such as tumor microenvironment regulators, epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors. The company was previously known as GNT Biotech & Medicals Corporation. Established in 2013, its headquarters are situated in Taipei City, Taiwan.
Prix de l'action
$2.33
Capitalisation boursière
$122.59M
Changement (1 jour)
0.41%
Changement (1 an)
110.45%
Pays
TW
Échange Great Novel Therapeutics Biotech & Medicals (7427)

Catégorie

Ratio P/S pour Great Novel Therapeutics Biotech & Medicals (7427)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Great Novel Therapeutics Biotech & Medicals, le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Great Novel Therapeutics Biotech & Medicals de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
10.17 -
US
10.13 -
NL
11.28 -
US
2.95 -
AU
- -
CH